WHO suspends Vaccine distribution via COVAXIN
WHO suspends Vaccine distribution via COVAXIN

World: The World Health Organisation (WHO) has suspended the supply of the COVID-19 vaccines via the United Nations agency – Covaxin, manufactured by Hyderabad-based firm Bharat Biotech. The reason for suspension by the international health agency has been stated as “to allow the manufacturer to upgrade facilities and address deficiencies found in an inspection.”   

Meanwhile, the official data shows that till March 31, 2022, around 71.1% of the world’s total population has received their at least one dose of the COVID-19 vaccines. On the other hand, nearly 60.2% of the global population has taken their recommended number of COVID-19 vaccines and is now fully immunized against the contagious pandemic.  


So far, only around 1.6% of the global population comes in the category of those who are fully vaccinated and have also taken their booster shots or third dose of the WHO-approved COVID vaccines. 

The international health body further asked the general public to abide by the COVID-19 containment measures and norms, as it reminds everyone that the “deadly pandemic” is not over yet. WHO is constantly encouraging people to get themselves vaccinated against the mutant as soon as possible. 

In addition, to tackle Dengue, Zika, Chikungunya, and Yellow fever, the World Health Organization has launched a global bug-busting plan Global Arbovirus Initiative, as shared by the United Nations news. 

“This week saw the UN launch an ambitious bid to halt the spread of common, mosquito-borne diseases – known as – “arboviruses” – which threaten more than half the world’s population. The main aim of the initiative is four of the most common arboviruses: Dengue, Yellow fever, chikungunya and Zika.

World Health Organization’s Dr Maria Van Kerkhove, in conversation with Daniel Johnson of the United Nations’ news, put light on how the Global Arbovirus Initiative plans to share expertise on bug-busting across continents.